1-4 of 4
Parisa R Khalighi, BS
Close
Sort by
Journal Articles

Comparative Effectiveness of Rasburicase Versus Allopurinol for Cancer Patients with Renal Dysfunction and Hyperuricemia

Kylee L Martens, MD, Parisa R Khalighi, BS, Shan Li, PharmD, Andrew A White, MD, Emily Silgard, MS, Deborah Frieze, PharmD, Elihu H. Estey, MD, David A. Garcia, MD, Sangeeta R Hingorani, MD MPH, Ang Li, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4674.
https://doi.org/10.1182/blood-2019-124058
Published: 2019
Journal Articles

The Platelet Factor-4 (PF4)-Dependent p-Selectin Expression Assay (PEA) Is Highly Accurate for the Detection of Pathogenic HIT Antibodies: Results of a 440-Sample Prospective Blinded Study

Deepti M. Warad, MD, Bethany T Samuelson Bannow, MD, Curtis Jones, BS, Shannon Pechauer, Brian R. Curtis, PhD, Daniel W. Bougie, PhD, Parisa R Khalighi, BS, Diane E. Grill, MS, Rachel Leger, BAE, Ruchika Sharma, MD, Dong Chen, MD PhD, Richard H. Aster, MD, David A. Garcia, MD, Anand Padmanabhan, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 416.
https://doi.org/10.1182/blood-2018-99-112475
Published: 2018
Journal Articles

External Validation of the Plasmic Score: A Clinical Prediction Tool for Thrombotic Thrombocytopenic Purpura (TTP) Diagnosis and Treatment

Parisa R Khalighi, BS, Qian Wu, PhD, David A Garcia, MD, Ang Li, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3646.
https://doi.org/10.1182/blood.V130.Suppl_1.3646.3646
Published: 2017
Journal Articles

HIT Diagnosis: A Proposed New Definition for Clinical Research

Parisa R Khalighi, BS, David A Garcia, MD, Anand Padmanabhan, MD PhD, Bethany T Samuelson Bannow, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3621.
https://doi.org/10.1182/blood.V130.Suppl_1.3621.3621
Published: 2017